Work done by Gresser and colleagues which examined the ability of IFN to reverse the phenotype of transformed and tumorigenic cells to a more normal phenotype showed a partial reversion in human osteosarcoma cells (OHA) but no reversion in bladder carcinoma EJ cells after long-term IFN treatment. The gene discussed is IFNA1; the disease is osteosarcoma.